DK1067941T3 - Antitumorpræparat indeholdende en synergistisk kombination af et anthracyclinderivat og et camptothecinderivat - Google Patents

Antitumorpræparat indeholdende en synergistisk kombination af et anthracyclinderivat og et camptothecinderivat

Info

Publication number
DK1067941T3
DK1067941T3 DK99914528T DK99914528T DK1067941T3 DK 1067941 T3 DK1067941 T3 DK 1067941T3 DK 99914528 T DK99914528 T DK 99914528T DK 99914528 T DK99914528 T DK 99914528T DK 1067941 T3 DK1067941 T3 DK 1067941T3
Authority
DK
Denmark
Prior art keywords
derivative
preparation containing
synergistic combination
anthracycline
tumor preparation
Prior art date
Application number
DK99914528T
Other languages
Danish (da)
English (en)
Inventor
Cristina Geroni
Marina Ripamonti
Michele Caruso
Antonino Suarato
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Application granted granted Critical
Publication of DK1067941T3 publication Critical patent/DK1067941T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK99914528T 1998-03-24 1999-03-19 Antitumorpræparat indeholdende en synergistisk kombination af et anthracyclinderivat og et camptothecinderivat DK1067941T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9806324.1A GB9806324D0 (en) 1998-03-24 1998-03-24 Antitumour synergetic composition
EP99914528A EP1067941B1 (en) 1998-03-24 1999-03-19 Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate

Publications (1)

Publication Number Publication Date
DK1067941T3 true DK1067941T3 (da) 2004-11-29

Family

ID=10829188

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99914528T DK1067941T3 (da) 1998-03-24 1999-03-19 Antitumorpræparat indeholdende en synergistisk kombination af et anthracyclinderivat og et camptothecinderivat

Country Status (29)

Country Link
US (1) US6403563B1 (uk)
EP (1) EP1067941B1 (uk)
JP (1) JP2002507571A (uk)
KR (1) KR20010034619A (uk)
CN (2) CN1150002C (uk)
AR (1) AR018166A1 (uk)
AT (1) ATE271388T1 (uk)
AU (1) AU758191B2 (uk)
BR (1) BR9908391A (uk)
CA (1) CA2324610A1 (uk)
CZ (1) CZ295368B6 (uk)
DE (1) DE69918819T2 (uk)
DK (1) DK1067941T3 (uk)
EA (1) EA003134B1 (uk)
ES (1) ES2226366T3 (uk)
GB (1) GB9806324D0 (uk)
HU (1) HUP0101615A3 (uk)
ID (1) ID26091A (uk)
IL (1) IL138035A0 (uk)
MY (1) MY133016A (uk)
NO (1) NO20004703L (uk)
NZ (1) NZ507570A (uk)
PL (1) PL343098A1 (uk)
PT (1) PT1067941E (uk)
SI (1) SI1067941T1 (uk)
TW (1) TW576740B (uk)
UA (1) UA63000C2 (uk)
WO (1) WO1999048503A1 (uk)
ZA (1) ZA992255B (uk)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6820065B1 (en) * 1998-03-18 2004-11-16 Ascom Hasler Mailing Systems Inc. System and method for management of postage meter licenses
GB9904387D0 (en) * 1999-02-25 1999-04-21 Pharmacia & Upjohn Spa Antitumour synergistic composition
GB9909925D0 (en) * 1999-04-29 1999-06-30 Pharmacia & Upjohn Spa Combined preparations comprising anthracycline derivatives
GB9916882D0 (en) * 1999-07-19 1999-09-22 Pharmacia & Upjohn Spa Antitumor synergistic composition
GB9926843D0 (en) * 1999-11-12 2000-01-12 Pharmacia & Upjohn Spa Lipid complex of alkycyclines
US6627614B1 (en) * 2002-06-05 2003-09-30 Super Gen, Inc. Sequential therapy comprising a 20(S)-camptothecin and an anthracycline
EP1985286A1 (en) * 2007-04-24 2008-10-29 Biocompatibles UK Limited Microspheres for treatment of brain tumours
US8349764B2 (en) 2007-10-31 2013-01-08 Molycorp Minerals, Llc Composition for treating a fluid
US20090107925A1 (en) * 2007-10-31 2009-04-30 Chevron U.S.A. Inc. Apparatus and process for treating an aqueous solution containing biological contaminants
US20110207760A1 (en) * 2010-02-23 2011-08-25 Valery Alakhov Sn-38 compositions
ES2609931T3 (es) 2010-06-18 2017-04-25 Myriad Genetics, Inc. Métodos y materiales para evaluar la pérdida de heterocigosidad
CA2807823C (en) 2010-08-24 2023-02-07 The Brigham And Women's Hospital, Inc. Methods for predicting anti-cancer response
US9233863B2 (en) 2011-04-13 2016-01-12 Molycorp Minerals, Llc Rare earth removal of hydrated and hydroxyl species
EP3693473A1 (en) 2011-06-17 2020-08-12 Myriad Genetics, Inc. Methods and materials for assessing allelic imbalance
FI2794907T4 (fi) 2011-12-21 2023-03-27 Menetelmiä ja materiaaleja heterotsygoottisuuden menettämisen arvioimiseksi
NZ628813A (en) 2012-02-23 2015-10-30 Univ Denmark Tech Dtu Methods for predicting anti-cancer response
CA3190075A1 (en) 2012-06-07 2013-12-12 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
US10308986B2 (en) 2013-03-14 2019-06-04 Children's Medical Center Corporation Cancer diagnosis, treatment selection and treatment
CA2908745C (en) 2013-04-05 2023-03-14 Myriad Genetics, Inc. Methods and materials for assessing homologous recombination deficiency
US11149316B2 (en) 2013-12-09 2021-10-19 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (BRCA1/2) in human tumors
AU2015226889B2 (en) 2014-03-07 2019-09-19 Secure Natural Resources Llc Cerium (IV) oxide with exceptional arsenic removal properties
CA2958801A1 (en) 2014-08-15 2016-02-18 Myriad Genetics, Inc. Methods and materials for assessing homologous recombination deficiency
EP4141127B1 (en) 2021-08-30 2024-10-09 Zentrum Familiärer Brust- und Eierstockkrebs Universitätsklinik Köln Method for assessing homologous recombination deficiency in ovarian cancer cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9114549D0 (en) * 1991-07-05 1991-08-21 Erba Carlo Spa Mono and bis alkylamino-anthracyclines
GB9325417D0 (en) * 1993-12-13 1994-02-16 Erba Carlo Spa 3'- aziridino-anthracycline derivatives

Also Published As

Publication number Publication date
ID26091A (id) 2000-11-23
AU3331499A (en) 1999-10-18
KR20010034619A (ko) 2001-04-25
DE69918819T2 (de) 2005-08-18
US6403563B1 (en) 2002-06-11
TW576740B (en) 2004-02-21
CN1294516A (zh) 2001-05-09
CZ295368B6 (cs) 2005-07-13
PL343098A1 (en) 2001-07-30
NZ507570A (en) 2003-01-31
IL138035A0 (en) 2001-10-31
NO20004703D0 (no) 2000-09-20
ES2226366T3 (es) 2005-03-16
CN1528334A (zh) 2004-09-15
ZA992255B (en) 1999-10-05
SI1067941T1 (en) 2005-02-28
NO20004703L (no) 2000-09-20
MY133016A (en) 2007-10-31
BR9908391A (pt) 2000-10-31
AR018166A1 (es) 2001-10-31
EA200000978A1 (ru) 2001-02-26
EP1067941A1 (en) 2001-01-17
EP1067941B1 (en) 2004-07-21
AU758191B2 (en) 2003-03-20
HUP0101615A3 (en) 2002-12-28
JP2002507571A (ja) 2002-03-12
HUP0101615A2 (hu) 2001-10-28
WO1999048503A1 (en) 1999-09-30
CZ20003493A3 (cs) 2001-02-14
CA2324610A1 (en) 1999-09-30
ATE271388T1 (de) 2004-08-15
UA63000C2 (en) 2004-01-15
EA003134B1 (ru) 2003-02-27
GB9806324D0 (en) 1998-05-20
DE69918819D1 (de) 2004-08-26
PT1067941E (pt) 2004-12-31
CN1150002C (zh) 2004-05-19

Similar Documents

Publication Publication Date Title
DK1067941T3 (da) Antitumorpræparat indeholdende en synergistisk kombination af et anthracyclinderivat og et camptothecinderivat
DK0785770T3 (da) Sammensætninger til bekæmpelse af hæmorroider og fremgangsmåde til anvendelse deraf
NO983965D0 (no) Polymer-organoleire-kompositter og deres fremstilling
IS6264A (is) Arýlmetýl-karbónýlamínó-þíósól afleiður og notkunþeirra sem miðla gegn æxlum
DK0540099T3 (da) Vandopløselige camptothecinderivater
FI965248A0 (fi) Kehikkorungon ja jalustan käsittävä kytkinkaappi
DK0939638T3 (da) Injektionsformuleringer af avermectiner og milbemyciner
FI930577A (fi) Vaccin och behandlingsmetod foer hiv-infektion
NO991560L (no) PDE IV-inhiberende 2-cyanoiminoimidazol-derivater
DK1200095T3 (da) Lægemiddel med protektiv virkning mod oxidativ-toksiske og især mod cardiotoksiske
DK2017269T3 (da) Krystallinsk form II af ritonavirindeholdende farmaceutisk sammensætning og fremstilling heraf
NO986174D0 (no) Triazinderivater og anvendelse derav
NO305804B1 (no) Krystallinsk maltitolblanding og fremstilling derav
NO20006576D0 (no) Et substituert triazol-pyridazinderivat og farmasöytiske preparater fremstilt av dette
DK0994706T3 (da) Præparater til oral indgivelse af taxaner og anvendelse deraf
DK1066261T3 (da) Pyridinderivat og farmaceutisk præparat indeholdende samme
DK1068194T3 (da) PDE IV-hæmmende pyridinderivater
FR2779146B1 (fr) Nouveaux derives de vinca-alcaloides et procedes de preparation
NO982030D0 (no) 1-arylsulfonyl-, arylkarbonyl- og aryltiokarbonylpyridazinoderivater og fremstilling derav
IL131372A (en) ((Substituted alkoxy)-7-alkyl camptothecin) derivatives and their preparation
IL127135A (en) ((Substituted alkoxy)-7-alkyl camptothecin) derivatives and their preparation
IT1284503B1 (it) Derivati tetraciclici spiro-condensati
ITMI941649A0 (it) Derivati tetraciclici spiro-condensati
SE9900101D0 (sv) ämpning och förfarande för dess framställning
FI980595A0 (fi) Foerfarande och anordning till golftraeningsredskap